Coverage
Source coverage by edition
Pick an edition to see what we cover and what we intentionally exclude.
AI
Daily briefings on AI labs, policy, tooling, and community shifts.
Featured signalUnlocked today
Coverage discusses speculative scenarios for 2026; treat as market chatter and see linked sources.
Included
- Model releases + evals
- Policy and safety narratives
- Tooling and platform shifts
Excluded
- No private roadmaps
- No behind-login scraping
Crypto
Daily briefings on markets, protocols, narratives, and risk events.
Featured signalUnlocked today
German stock exchange operator Deutsche Börse has acquired a $200 million stake in Kraken's parent company, Payward, representing a 1.5% fully diluted owners...
Included
- Market structure + regulation
- Security and exploit narratives
- Protocol + dev ecosystem
Excluded
- No paid terminals
- No private communities
CYBERSECURITY
Daily briefings on vulnerabilities, incidents, and threat intel.
Featured signalUnlocked today
Anthropic's Mythos AI model, designed to identify and exploit cybersecurity vulnerabilities rapidly, is driving a new era of high-velocity cyberattacks.
Included
- Vulns and advisories
- Incidents + exploit narratives
- Vendor and community disclosures
Excluded
- No active scanning
- No private intel feeds
ENERGY
Daily briefings on the energy transition: policy, grid, storage, and markets.
Featured signalUnlocked today
Suniva is investing $350 million to build a new 4.5 GW solar cell manufacturing facility in Laurens, South Carolina, expected to start operations in Q2 2027.
Included
- Grid + reliability narratives
- Policy + first-party data
- Storage + transition supply chain
Excluded
- No paid data terminals
- No private project databases
BIOTECH
Daily briefings on clinical, regulatory, and R&D updates from public sources.
Featured signalUnlocked today
Travere Therapeutics has received FDA approval for Filspari to treat focal segmental glomerulosclerosis (FSGS), marking a significant milestone in addressing...
Included
- Clinical + regulatory narratives
- Research + preprints
- Funding + market updates
Excluded
- No protected patient data
- No paywalled clinical DBs